This hypothesis was initially proposed by Fournier et al [1] after consistent findings of a reduction in stroke risk with ARBs, CCBs and diuretics in numerous clinical trials and similarity in terms of mechanism of Ang II formation in these drugs. Here, AGT is linked to stroke disorder.